JP2014533681A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014533681A5 JP2014533681A5 JP2014541807A JP2014541807A JP2014533681A5 JP 2014533681 A5 JP2014533681 A5 JP 2014533681A5 JP 2014541807 A JP2014541807 A JP 2014541807A JP 2014541807 A JP2014541807 A JP 2014541807A JP 2014533681 A5 JP2014533681 A5 JP 2014533681A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- seq
- set forth
- sequence set
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161561080P | 2011-11-17 | 2011-11-17 | |
| US61/561,080 | 2011-11-17 | ||
| US201261583745P | 2012-01-06 | 2012-01-06 | |
| US61/583,745 | 2012-01-06 | ||
| PCT/IB2012/056533 WO2013072901A2 (en) | 2011-11-17 | 2012-11-18 | Compositions and methods for treating glioma |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014533681A JP2014533681A (ja) | 2014-12-15 |
| JP2014533681A5 true JP2014533681A5 (enExample) | 2016-01-14 |
| JP6426001B2 JP6426001B2 (ja) | 2018-11-21 |
Family
ID=47358252
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014541807A Expired - Fee Related JP6426001B2 (ja) | 2011-11-17 | 2012-11-18 | 神経膠腫を治療するための組成物および方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US9453050B2 (enExample) |
| EP (1) | EP2780363B1 (enExample) |
| JP (1) | JP6426001B2 (enExample) |
| KR (1) | KR20140103122A (enExample) |
| CA (1) | CA2856329A1 (enExample) |
| IL (1) | IL232648B (enExample) |
| WO (1) | WO2013072901A2 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201220573D0 (en) | 2012-11-15 | 2013-01-02 | Univ Central Lancashire | Methods of diagnosing proliferative disorders |
| DE102014207498A1 (de) * | 2014-04-17 | 2015-10-22 | Universitätsklinikum Hamburg-Eppendorf | Viraler Vektor für den zielgerichteten Gentransfer in Gehirn und Rückenmark |
| WO2016048247A1 (en) * | 2014-09-26 | 2016-03-31 | National University Of Singapore | Methods and compositions for modulating th-gm cell function |
| US11078264B2 (en) | 2018-10-17 | 2021-08-03 | University Of Connecticut | Inhibiting granulocyte macrophage-colony stimulating factor (GM-CSF) prevents preterm birth |
| EP3886888A4 (en) * | 2018-11-28 | 2022-09-28 | Glia Sp. z o.o. | COMPOSITIONS AND METHODS OF TREATMENT OF GLIOMA |
| CN112007142B (zh) * | 2019-05-31 | 2025-04-22 | 生物蚕茧研究所股份有限公司 | 向抗炎m2表型小胶质细胞的极性转化促进剂 |
| KR102758046B1 (ko) * | 2021-11-05 | 2025-01-23 | (주) 넥셀 | 궤양성 대장염 예방 또는 치료용 재조합 단백질 및 이를 포함하는 궤양성 대장염 예방 또는 치료용 조성물 |
| PL441229A1 (pl) * | 2022-05-19 | 2023-11-20 | Instytut Biologii Doświadczalnej im. Marcelego Nenckiego Polska Akademia Nauk | Zaprojektowane, syntetyczne peptydy, zawierające je kompozycje i sposoby ich zastosowania w leczeniu glejaków złośliwych |
| KR102899196B1 (ko) * | 2023-01-20 | 2025-12-12 | (주) 넥셀 | 치주염 및 임플란트 주변염 예방 또는 치료용 재조합 단백질 및 이를 포함하는 치주염 및 임플란트 주변염 예방 또는 치료용 조성물 |
| CN116650650A (zh) * | 2023-06-12 | 2023-08-29 | 郑州大学 | 一种抑制食管鳞癌中肿瘤相关巨噬细胞浸润的方法 |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6150090A (en) | 1986-01-09 | 2000-11-21 | Massachusetts Institute Of Technology | Nuclear factors associated with transcriptional regulation |
| NZ234479A (en) * | 1989-07-14 | 1992-03-26 | Schering Corp | Antagonists of gm-csf derived from the carboxyl terminus, antibodies, hybridomas and pharmaceutical compositions containing anti-idiotypic antibodies |
| DK0486572T3 (da) * | 1989-08-11 | 1998-05-04 | Amrad Corp Ltd | Forbedringer i granulocyt-makrofag-kolonistimulerende faktorreceptor og derivater deraf |
| AUPN780096A0 (en) * | 1996-01-30 | 1996-02-22 | Medvet Science Pty. Ltd. | Cytokine antagonists and agonists |
| US5837231A (en) * | 1996-06-27 | 1998-11-17 | Regents Of The University Of Minnesota | GM-CSF administration for the treatment and prevention of recurrence of brain tumors |
| US6372720B1 (en) | 1998-02-05 | 2002-04-16 | Kenneth J. Longmuir | Liposome fusion and delivery vehicle |
| AU756916B2 (en) | 1998-11-12 | 2003-01-23 | Jcr Pharmaceuticals Co., Ltd. | Modulation of cell proliferative disorders by cyclic RGD |
| US6551990B2 (en) * | 1998-12-07 | 2003-04-22 | University Of Washington | Methods of inhibiting ectopic calcification |
| WO2000038715A2 (en) | 1998-12-23 | 2000-07-06 | G.D. Searle & Co. | Use of an integrin antagonist and radiation in the treatment of neoplasia |
| US6521593B1 (en) | 1999-02-01 | 2003-02-18 | Childrens Hospital Los Angeles | Methods for inhibiting brain tumor growth |
| US7060279B2 (en) * | 2000-03-30 | 2006-06-13 | Dendreon Corporation | Compositions and methods for dendritic cell-based immunotherapy |
| US7767802B2 (en) | 2001-01-09 | 2010-08-03 | Alnylam Pharmaceuticals, Inc. | Compositions and methods for inhibiting expression of anti-apoptotic genes |
| US7611711B2 (en) * | 2001-01-17 | 2009-11-03 | Vegenics Limited | VEGFR-3 inhibitor materials and methods |
| WO2003015698A2 (en) | 2001-08-13 | 2003-02-27 | University Of Pittsburgh | Application of lipid vehicles and use for drug delivery |
| WO2004018498A2 (en) * | 2002-05-10 | 2004-03-04 | Children's Medical Center Corporation | Minicell display and products therefrom |
| EP1848453B1 (en) * | 2005-02-18 | 2010-10-27 | Proximagen Ltd. | Treatment for neurodegeneration |
| EP2377884A1 (en) * | 2005-05-10 | 2011-10-19 | Neoloch Aps | Neuritogenic peptides |
| JP2009508650A (ja) * | 2005-09-21 | 2009-03-05 | ダスク テクノロジーズ， エルエルシー | 臓器および組織機能のための方法および組成 |
| KR20080089489A (ko) | 2006-01-18 | 2008-10-06 | 메르크 파텐트 게엠베하 | 인테그린 리간드를 사용하는 암치료용 특이적 요법 |
| KR101481844B1 (ko) * | 2006-03-27 | 2015-01-13 | 메디뮨 리미티드 | Ｇｍ-ｃｓｆ 수용체에 대한 결합 성분 |
| DK2121586T3 (en) | 2007-03-09 | 2017-06-19 | Pathologica Llc | MGBG FOR THE REGULATION OF OSTEOPONTIN AND THE TREATMENT OF MULTIPLE SCLEROSIS |
| DK2201138T3 (en) | 2007-10-16 | 2015-05-18 | Ventana Med Syst Inc | GRADING, STAGE DETERMINATION AND FORECAST OF CANCER USING osteopontin-C |
| WO2009094172A2 (en) * | 2008-01-22 | 2009-07-30 | Araim Pharmaceuticals, Inc. | Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage |
| AU2009317549A1 (en) | 2008-11-20 | 2011-07-07 | Merck Patent Gmbh | New therapy and medicament using integrin ligands for treating cancer |
| AU2010252280A1 (en) | 2009-05-25 | 2012-01-19 | Merck Patent Gmbh | Continuous administration of cilengitide in cancer treatments |
| CA2798074A1 (en) * | 2010-04-27 | 2011-11-03 | The Johns Hopkins University | Immunogenic compositions and methods for treating neoplasia |
-
2012
- 2012-11-18 KR KR1020147016562A patent/KR20140103122A/ko not_active Ceased
- 2012-11-18 JP JP2014541807A patent/JP6426001B2/ja not_active Expired - Fee Related
- 2012-11-18 EP EP12801640.9A patent/EP2780363B1/en not_active Not-in-force
- 2012-11-18 WO PCT/IB2012/056533 patent/WO2013072901A2/en not_active Ceased
- 2012-11-18 CA CA2856329A patent/CA2856329A1/en not_active Abandoned
-
2014
- 2014-05-15 IL IL232648A patent/IL232648B/en unknown
- 2014-05-16 US US14/280,095 patent/US9453050B2/en not_active Expired - Fee Related
-
2016
- 2016-08-09 US US15/232,165 patent/US20170035851A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2019010736A (es) | Inhibidor del antigeno de superficie del virus de la hepatitis b. | |
| JP2013520405A5 (enExample) | ||
| CN114901681A (zh) | 胰岛素衍生物 | |
| JP2020023567A5 (enExample) | ||
| FI4374873T3 (fi) | Aine käytettäväksi silmäsairauksien hoidossa tai ehkäisyssä | |
| WO2013101897A3 (en) | Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid | |
| WO2014205317A3 (en) | Cyclic peptides as protein targeting agents | |
| HRP20190982T1 (hr) | Peptidi i njihova uporaba | |
| JP2014169326A5 (enExample) | ||
| PH12013500172A1 (en) | Use of binders for manufacturing storage stable formulations | |
| JP2016513638A5 (enExample) | ||
| JP2013172734A5 (enExample) | ||
| UY32833A (es) | Antagonistas dp2 y usos del mismo | |
| JP2015517488A5 (enExample) | ||
| JP2014050390A5 (enExample) | ||
| JP2015510393A5 (enExample) | ||
| JP2014508138A5 (enExample) | ||
| JP2017507142A5 (enExample) | ||
| FI3065763T4 (fi) | Il-22-dimeerin käyttö lääkkeen valmistamisessa suonensisäistä antoa varten | |
| FI3666258T3 (fi) | Menetelmä prader-willin oireyhtymän hoitamiseksi | |
| JP2017512194A5 (enExample) | ||
| JP2014532722A5 (enExample) | ||
| MX351059B (es) | Composicion farmaceutica oral en forma de microesferas y proceso de elaboracion. | |
| EA201500513A1 (ru) | Продукт сомикронизации, включающий ацетат улипристала | |
| JP2012092108A5 (enExample) |